BioTime, Inc. (BTX) Reports Q4 Loss of $0.10

BioTime, Inc. (NYSE: BTX) reported Q4 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $1.6 million, versus $1.4 million reported last year.

For earnings history and earnings-related data on BioTime, Inc. (BTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Greenlane Holdings Inc. (GNLN) reported Q2 result